Polypeptide models to understand misfolding and amyloidogenesis and their relevance in protein design and therapeutics.
The study of amyloid polypeptide models (polypeptides able to generate amyloid structures not necessarily connected with any pathology) provides an excellent tool to increase the understanding of the generic aspects of misfolding and aggregation as well as the details of the mechanism of polypeptide deposition in disease. This knowledge can be integrated and applied to different problems in therapy and biotechnology, and in particular to re-designing bio-active polypeptides (biopharmaceuticals) with improved properties.
Zurdo
Jesús
J
Leverhulme Centre for Biological Complexity. Department of Chemistry, University of Cambridge. Lensfield Road, Cambridge CB2 1EW, UK. jz226@cam.ac.uk
D000465:Algorithms; D000682:Amyloid / Q000096:biosynthesis* / Q000648:ultrastructure; D000686:Amyloidosis / Q000209:etiology / Q000378:metabolism / Q000473:pathology; D006801:Humans; D008958:Models, Molecular; D010455:Peptides / Q000737:chemistry* / Q000378:metabolism; D011487:Protein Conformation; D015202:Protein Engineering; D017510:Protein Folding
D000682:Amyloid; D010455:Peptides